Trial Profile
Safety amd tolerability of ocaperidone in the continuation treatment of patients with schizophrenia: a double-blind, parallel group, multicentre, fixed dose, follow-up study.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 21 Jan 2020
Price :
$35
*
At a glance
- Drugs Ocaperidone (Primary) ; Olanzapine
- Indications Schizophrenia
- Focus Adverse reactions
- Sponsors Neuro3d
- 22 Jul 2011 New trial record